Trivalent influenza virus vaccine

BIOLOGICAL2 trials

Sponsors

MedImmune LLC

Conditions

Influenza

Phase 4

A Prospective Study to Evaluate the Safety of a New Trivalent Intranasal Influenza Vaccine

CompletedNCT00677820

MedImmune LLCInfluenza

Start: 2008-06-30End: 2008-12-31Updated: 2010-10-22

A Study to Evaluate the Safety of 3 New 6:2 Influenza Virus Reassortants in Adults

CompletedNCT01579916

MedImmune LLCInfluenza

Start: 2012-05-31End: 2012-11-30Updated: 2014-02-03